Search hospitals > California > Palo Alto
Stanford University School of Medicine
Claim this profilePalo Alto, California 94304
Global Leader in Parotid Gland Cancer
Global Leader in Cancer
Conducts research for Subtalar Arthritis
Conducts research for Rheumatoid Arthritis
Conducts research for Lymphoma
152 reported clinical trials
32 medical researchers
Summary
Stanford University School of Medicine is a medical facility located in Palo Alto, California. This center is recognized for care of Parotid Gland Cancer, Cancer, Subtalar Arthritis, Rheumatoid Arthritis, Lymphoma and other specialties. Stanford University School of Medicine is involved with conducting 152 clinical trials across 321 conditions. There are 32 research doctors associated with this hospital, such as Andrei Iagaru, MD, Robert Lowsky, MD, Christopher Chen, and Everett Meyer, MD.Area of expertise
1Parotid Gland Cancer
Global Leader2Cancer
Global LeaderCD19 positive
Stage IV
CD22 negative
Top PIs
Andrei Iagaru, MDStanford University1 year of reported clinical research
Studies Prostatic Neoplasm
Studies Prostate Cancer
15 reported clinical trials
21 drugs studied
Robert Lowsky, MDStanford University2 years of reported clinical research
Studies Immune Tolerance
Studies Leukemia
14 reported clinical trials
22 drugs studied
Christopher ChenStanford Cancer Institute2 years of reported clinical research
Studies Colorectal Cancer
Studies Cancer
13 reported clinical trials
19 drugs studied
Everett Meyer, MDStanford University2 years of reported clinical research
Studies Acute Lymphoblastic Leukemia
Studies Leukemia
12 reported clinical trials
23 drugs studied
Clinical Trials running at Stanford University School of Medicine
Epilepsy
Lung Cancer
Major Depressive Disorder
Cancer
Autism Spectrum Disorder
Depression
Brain Tumor
Vitiligo
Critical Limb Ischemia
Pulmonary Arterial Hypertension
Ketamine
for Dissociative Symptoms
The purpose of this study is to understand how ketamine brings about dissociative symptoms.
Recruiting3 awards Phase 12 criteria
Focused Ultrasound
for Epilepsy
This will be a prospective, open-label, single-arm, multi-center, pilot study to evaluate the safety, tolerability, and preliminary efficacy of low-intensity focused ultrasound (LIFU) neuromodulation using NaviFUS System in patients with drug-resistant unilateral or bilateral temporal lobe epilepsy (DR-TLE).
Recruiting1 award Phase 1 & 25 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Stanford University School of Medicine?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.